There are 26 papers on perimenopausal syndrome in aging research: 6 trials and 3 observational studies in people, 4 in animals, 9 reviews.
26 papers study it7 more mention it18 findings
4 new papers in 30 daysSee all 33 papers on perimenopausal syndrome
“Bayesian network analysis identified statistical direct correlations between the noise exposure levels and perimenopausal syndrome”
- Human trial6
- Humans3
- Animals4
- In silico1
Interventions
7Bhramari pranayama
downin humans1
1 study
Bhramari pranayama
downin humans1
Bhramari pranayama decreases perimenopausal syndrome in humans (p<0.001).
“Statistical analysis revealed a highly significant improvement (p<0.001) in the overall menopausal symptom score.”
Human trialfemalesn = 52
AYUSHDHARA
Kuntai capsule
downin humans1
1 study
Kuntai capsule
downin humans1
Kuntai capsule decreases perimenopausal syndrome in humans (combined with low-dose Femoston versus low-dose Femoston alone) (MD = -4.36, 95% CI (-4.93, -3.79)).
“adjunctive KTC significantly improved the clinical response rate [RR = 1.17, 95% CI (1.10, 1.23)] and reduced Kupperman scores [MD = -4.36, 95% CI (-4.93, -3.79)].”
Reviewcombined with low-dose Femoston versus low-dose Femoston alone
Efficacy of Kuntai capsules with low-dose Femoston for perimenopausal syndrome: a meta-analysis
Frontiers in medicine
Ayurvedic management
downin humans1
1 study
Ayurvedic management
downin humans1
Ayurvedic management decreases perimenopausal syndrome in humans (perimenopausal syndrome).
“Significant improvement was observed in the frequency of hot flashes, sleep quality, menstrual regularity, and emotional stability.”
Human trialperimenopausal syndromesix monthsfemales
Ayurvedic management of perimenopausal syndrome: A case study
Journal of Pharmacognosy and Phytochemistry
Seawater pearl hydrolysate
downin rats1
1 study
Seawater pearl hydrolysate
downin rats1
Seawater pearl hydrolysate decreases perimenopausal syndrome in ovariectomized rats.
“SPH ameliorated behavioural deficits, restored estrous cycles, improved uterine histoarchitecture, and normalised serum hormone levels (E2, P, FSH, LH).”
Animalsin ovariectomized rats15 days
Frontiers in pharmacology
Moxibustion
downin humans1
1 study
Moxibustion
downin humans1
Moxibustion decreases perimenopausal syndrome in humans (comparison of acupuncture modalities) (Highest overall effectiveness).
“moxibustion (M) showed the highest overall effectiveness.”
Reviewcomparison of acupuncture modalitiesfemales
Frontiers in neurology
Chai-shen powder
downin humans1−87% effective rate
1 study
Chai-shen powder
downin humans1−87% effective rate
Chai-shen powder decreases perimenopausal syndrome in humans (87.33% effective rate).
“Data mining showed that the effective rate of CSP was 87.33%”
Human trialn = 100
Climacteric : the journal of the International Menopause Society
Chaihu shugan san
downin humans1
1 study
Chaihu shugan san
downin humans1
Chaihu shugan san decreases perimenopausal syndrome in humans (perimenopausal syndrome).
“Numerous clinical experiments and pharmacological studies have confirmed that CSS has a significant effect on PMS treatment.”
Reviewperimenopausal syndromefemales
Research progress on Chaihu Shugan San in treating perimenopausal syndrome: A review
Medicine
Effects
1Quality of life
downin reviews1
1 study
Quality of life
downin reviews1
Perimenopausal syndrome impairs quality of life.
“The life quality of women troubled by perimenopausal syndrome has been significantly reduced”
Review
Advances in diagnosis and treatment of perimenopausal syndrome
Open life sciences
Associations
10Occupational noise exposure and psychological distress
upin humans1
1 study
Occupational noise exposure and psychological distress
upin humans1
Occupational noise exposure and psychological distress is associated with perimenopausal syndrome in humans (combined occupational noise exposure and psychological distress in perimenopausal workers) (Relative excess risk due to interaction 1.10 (95% CI: 0.36–1.84); excess risk 21.63% (95% CI: 2.02–45.01); synergy index 2.53 (95% CI: 1.30–12.53)).
“The GAM confirmed a significant interaction only for perimenopausal syndrome, with a relative excess risk due to interaction of 1.10 (95% CI: 0.36–1.84)”
Humanscombined occupational noise exposure and psychological distress in perimenopausal workersfemalesn = 1,030
Noise & health
More on Occupational noise exposure and psychological distress
Occupational noise exposure
mixedin humans1
1 study
Occupational noise exposure
mixedin humans1
Occupational noise exposure is associated with perimenopausal syndrome in humans (perimenopausal workers).
“Bayesian network analysis identified statistical direct correlations between the noise exposure levels and perimenopausal syndrome”
Humansperimenopausal workersfemalesn = 1,030
Noise & health
Angelica sinensis–ligusticum chuanxiong–rehmannia glutinosa
upin silico1
1 study
Angelica sinensis–ligusticum chuanxiong–rehmannia glutinosa
upin silico1
Angelica sinensis–ligusticum chuanxiong–rehmannia glutinosa is associated with perimenopausal syndrome in silico (herb–phenotype association rule mining) (all Z_h values below −0.15).
“ARM identified six core herbal combinations for PMS, two for anxiety, two for insomnia, and two for depression”
In silicoherb–phenotype association rule mining
Research SquarePreprint
More on Angelica sinensis–ligusticum chuanxiong–rehmannia glutinosa
Microbiome composition
mixedin rats1
1 study
Microbiome composition
mixedin rats1
Perimenopausal syndrome is associated with microbiome composition in rats (rat model of perimenopausal syndrome vs control).
“revealed significant variability in the composition of the intestinal flora between the normal control and perimenopausal groups”
Animalsrat model of perimenopausal syndrome vs controlstoolfemales
Integrated analysis of metabolome and microbiome in a rat model of perimenopausal syndrome
mSystems
Metabolome
mixedin rats1
1 study
Metabolome
mixedin rats1
Perimenopausal syndrome is associated with metabolome in rats (rat model of perimenopausal syndrome vs control).
“Orthogonal partial least-squares discriminant analysis scores and replacement tests indicated distinct separations of anion and cation levels between serum and intestinal samples of the model and control groups.”
Animalsrat model of perimenopausal syndrome vs controlserum and intestinefemales
Integrated analysis of metabolome and microbiome in a rat model of perimenopausal syndrome
mSystems
Sufficient manpower
downin humans1OR 0.915
1 study
Sufficient manpower
downin humans1OR 0.915
Sufficient manpower is associated with perimenopausal syndrome in humans (clinical nurses in Chongqing) (OR 0.915, 95% CI 0.855–0.979).
“sufficient manpower (OR =0.915, 95% CI: 0.855-0.979) were protective factors for perimenopausal syndrome in clinical nurses.”
Humansclinical nurses in Chongqingn = 933
Annals of palliative medicine
Basic security
downin humans1OR 0.939
1 study
Basic security
downin humans1OR 0.939
Basic security is associated with perimenopausal syndrome in humans (clinical nurses in Chongqing) (OR 0.939, 95% CI 0.887–0.994).
“basic security (OR =0.939, 95% CI: 0.887-0.994), and sufficient manpower (OR =0.915, 95% CI: 0.855-0.979) were protective factors for perimenopausal syndrome”
Humansclinical nurses in Chongqingn = 933
Annals of palliative medicine
Exercise
upin humans1OR 2.689
1 study
Exercise
upin humans1OR 2.689
Exercise is associated with perimenopausal syndrome in humans (clinical nurses in Chongqing) (OR 2.689, 95% CI 1.516–4.768).
“exercising 1-5 times per week (OR =2.689, 95% CI: 1.516-4.768) were risk factors for perimenopausal syndrome”
Humansclinical nurses in Chongqing1-5 times per weekn = 933
Annals of palliative medicine
Menopause
upin humans1OR 1.989
1 study
Menopause
upin humans1OR 1.989
Menopause is associated with perimenopausal syndrome in humans (clinical nurses in Chongqing) (OR 1.989, 95% CI 1.198–3.303).
“menopause (OR =1.989, 95% CI: 1.198-3.303)”
Humansclinical nurses in Chongqingn = 933
Annals of palliative medicine
Chronic disease
upin humans1OR 1.659
1 study
Chronic disease
upin humans1OR 1.659
Chronic disease is associated with perimenopausal syndrome in humans (clinical nurses in Chongqing) (OR 1.659, 95% CI 1.095–2.512).
“the presence of chronic diseases (OR =1.659, 95% CI: 1.095-2.512)”
Humansclinical nurses in Chongqingn = 933
Annals of palliative medicine
Trial sponsors
1 trialPhase 4100 people
Nanchang Reproductive Hospital
1 trialPhase 450 people
1 trialPhase 430 people
Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology
1 trial50 people